Hints and tips:
...Shares fell 1.7 per cent on Thursday and its biopharma unit, under investigation for accounting fraud, dropped nearly 4.9 per cent while the benchmark Kospi Composite index eased 0.4 per cent....
South Korean regulator says biopharma company dropped crucial information on joint venture
Shares in biopharma unit down by as much as 20%
...Michael Na, strategist at Nomura, said: “The success of the biopharma business would be good for trumpeting Mr Lee’s achievements....
...Samantha Westgate Chief Executive, Perfectus Biomed Dr Conor Mulrooney Chief Operating Officer, Phagenesis Dr Chris Torrance Chief Executive, PhoreMost Santoke Naal Managing Director, Pierre Fabre Ltd...
...Canada’s Tekmira Pharmaceuticals also joined the fray by agreeing to merge with OnCore Biopharma of the US in an all-paper deal to combine forces in developing treatments for hepatitis B....
International Edition